1
|
Wang Y, Xu F, Yuan C, Zhang Y, Ren J, Yue H, Ma T, Song Q. Comparison of immune effects of porcine circovirus type 2d (PCV2d) capsid protein expressed by Escherichia coli and baculovirus-insect cells. Vaccine 2024; 42:2848-2857. [PMID: 38514351 DOI: 10.1016/j.vaccine.2024.03.048] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/15/2023] [Revised: 03/15/2024] [Accepted: 03/18/2024] [Indexed: 03/23/2024]
Abstract
Porcine circovirus type 2 (PCV2) is an important pathogen harmful to global pig production, which causes immunosuppression and serious economic losses. PCV2 capsid (Cap) protein expressed by E. coli or baculovirus-insect cells are often used in preparation of PCV2 subunit vaccines, but the latter is expensive to produce. It is therefore crucial to comparison of the immune effects of Cap protein expressed by the above two expression systems for reducing the production cost and guaranteeing PCV2 vaccine quality. In this study, the PCV2d-Cap protein lacking nuclear localization signal (NLS), designated as E. coli-Cap and Bac-Cap, was expressed by E. coli and baculovirus-Spodoptera frugiperda Sf9 (Bac-Sf9) cells, respectively. The expressed Cap proteins could self-assemble into virus-like particles (VLPs), but the Bac-Cap-assembled VLPs were more regular. The two system-expressed Cap proteins induced similar specific IgG responses in mice, but the neutralizing antibody levels of Bac-Cap-immunized mice was higher than those of E. coli-Cap. After PCV2 challenge, IL-10 in Bac-Cap immunized mice decreased significantly than that in E. coli-Cap. The lesions and PCV2 antigen positive cells in tissues of mice immunized with E. coli-Cap and Bac-Cap were significantly reduced, and Bac-Cap appeared mild lesions and fewer PCV2 antigen-positive cells compared with E. coli-Cap immunized mice. The study indicated that Cap proteins expressed by E. coli and Bac-Sf9 cells could induce specific protective immunity, but the latter induced more effective immunity, which provides valuable information for the research and development of PCV2 vaccine.
Collapse
Affiliation(s)
- Yawen Wang
- College of Veterinary Medicine & Hebei Veterinary Biotechnology Innovation Center, Hebei Agricultural University, Baoding 071001, China
| | - Fan Xu
- College of Veterinary Medicine & Hebei Veterinary Biotechnology Innovation Center, Hebei Agricultural University, Baoding 071001, China
| | - Chen Yuan
- College of Veterinary Medicine & Hebei Veterinary Biotechnology Innovation Center, Hebei Agricultural University, Baoding 071001, China
| | - Yanan Zhang
- College of Veterinary Medicine & Hebei Veterinary Biotechnology Innovation Center, Hebei Agricultural University, Baoding 071001, China
| | - Jing Ren
- College of Veterinary Medicine & Hebei Veterinary Biotechnology Innovation Center, Hebei Agricultural University, Baoding 071001, China
| | - Huaining Yue
- College of Veterinary Medicine & Hebei Veterinary Biotechnology Innovation Center, Hebei Agricultural University, Baoding 071001, China
| | - Tiantian Ma
- College of Veterinary Medicine & Hebei Veterinary Biotechnology Innovation Center, Hebei Agricultural University, Baoding 071001, China
| | - Qinye Song
- College of Veterinary Medicine & Hebei Veterinary Biotechnology Innovation Center, Hebei Agricultural University, Baoding 071001, China.
| |
Collapse
|
2
|
Lippke RT, De Conti ER, Hernig LF, Teixeira AP, de Quadros FA, Fiúza AT, Pereira JB, Ulguim RDR, Barcellos DESN, Takeuti KL. Assessment of sow herd frequency of PCV-2 using placental umbilical cord serum and serology in 18 breeding farms in Brazil. Front Vet Sci 2024; 11:1368644. [PMID: 38650853 PMCID: PMC11034369 DOI: 10.3389/fvets.2024.1368644] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/11/2024] [Accepted: 03/13/2024] [Indexed: 04/25/2024] Open
Abstract
Porcine circovirus type 2 (PCV-2) is the agent of one of the most important diseases in the swine industry. Although it has been controlled through vaccination, viremic piglets at birth may represent a risk by reducing vaccination efficacy. Since there are few reports on the viremic status of pre-suckling piglets regarding PCV-2 infection, we assessed the PCV-2 frequency in sows housed in 18 breeding farms with no history of clinical PCVAD in Brazil, using placental umbilical cord serum (PUCS). The selection criteria were: breeding farms with more than 1,000 sows; sows not vaccinated for PCV-2 at least for 2 years prior to the study; farms with no history of PCV-2 clinical disease in the last 12 months; and production systems with a maximum of two sites. Blood from the umbilical cords in sow placenta or directly from piglet's immediately after birth was collected from 30 litters on each farm for PCR. In addition, blood from 538 sows was collected for PCV-2 antibody detection. A total of 17.29% of the PUCS tested positive. The PCV-2 DNA was detected in PUCS from 94.4% of all farms. A total of 94.8% of the sows was positive for PCV-2 antibodies. However, seronegative sows were detected in 44.4% of farms. All 18 farms had at least 46.9% seropositive dams. A higher percentage of seronegative sows was observed for farms with more than 10% of PCV-2-positive litters compared to those with ≤10% of PCV-2 positive litters (8.9 +/-1.7% vs. 1.5 +/- 0.7%, p < 0.01, respectively).
Collapse
Affiliation(s)
- Ricardo T. Lippke
- Boehringer-Ingelheim Animal Health do Brasil, São Paulo, Brazil
- Setor de Suínos, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil
| | | | | | | | | | | | | | | | | | | |
Collapse
|
3
|
Sagrera M, Garza-Moreno L, Sibila M, Oliver-Ferrando S, Cárceles S, Casanovas C, Prieto P, García-Flores A, Espigares D, Segalés J. Frequency of PCV-2 viremia in nursery piglets from a Spanish swine integration system in 2020 and 2022 considering PRRSV infection status. Porcine Health Manag 2024; 10:4. [PMID: 38229182 DOI: 10.1186/s40813-024-00354-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/23/2023] [Accepted: 01/05/2024] [Indexed: 01/18/2024] Open
Abstract
BACKGROUND Porcine circovirus 2 (PCV-2) poses a significant economic threat for the swine industry, causing a range of diseases collectively referred to as porcine circovirus diseases (PCVDs). Despite PCV-2 vaccine effectiveness, the need for monitoring infectious pressure remains. PCV-2 coinfection with other pathogens like porcine reproductive and respiratory syndrome virus (PRRSV) can exacerbate disease severity and lead to PCV-2-systemic disease cases. Monitoring both PRRSV and PCV-2 in co-infected farms is crucial for an effective management and vaccination programs. The present cross-sectional study aimed to determine PCV-2 antibody levels in piglets at weaning and PCV-2 and PRRSV viremia in pooled serum samples at weaning (vaccination age) and at 6 and 9 weeks of age from a Spanish swine integration system in 2020 (48 farms) and in 2022 (28 out of the 48 analysed previously). RESULTS The frequency of PCV-2 detection in pools of piglet sera was 2.1% (2020) and 7.1% (2022) at vaccination age but increased at the end of the nursery period (10.4% in 2020 and 39.3% in 2022) in both years. Co-infections between PCV-2 and PRRSV were detected in a significant proportion of PRRSV positive farms (15% in 2020, and 60% in 2022). PCV-2 antibody levels (ELISA S/P ratios) at weaning were lower in PCV-2 qPCR positive farms at different sampling time-points (0.361 in 2020 and 0.378 in 2022) compared to PCV-2 qPCR negative ones (0.587 in 2020 and 0.541 in 2022). The 28 farms tested both years were classified in four different epidemiological scenarios depending on their PCV-2 virological status. Those PCV-2 qPCR negative farms in 2020 that turned to be positive in 2022 had a statistically significant increase of PRRSV RT-qPCR detection and a PCV-2 antibody levels reduction, facts that were not observed in the rest of the scenarios. CONCLUSION This epidemiological study in farms from the same integration system determined the occurrence, in 2020 and in 2022, of PCV-2 and PRRSV infections in piglets during the nursery period by using pooled serum samples.
Collapse
Affiliation(s)
- Mònica Sagrera
- IRTA. Programa de Sanitat Animal, Centre de Recerca en Sanitat Animal (CReSA, IRTA-UAB), Campus de La UAB, 08193, Bellaterra, Cerdanyola del Vallès, Spain
- Unitat Mixta d'Investigació IRTA-UAB en Sanitat Animal, Centre de Recerca en Sanitat Animal (CReSA), Campus de la Universitat Autònoma de Barcelona (UAB), 08193, Bellaterra, Barcelona, Spain
- Ceva Salud Animal, Avenida Diagonal, 609-615, 08028, Barcelona, Spain
| | | | - Marina Sibila
- IRTA. Programa de Sanitat Animal, Centre de Recerca en Sanitat Animal (CReSA, IRTA-UAB), Campus de La UAB, 08193, Bellaterra, Cerdanyola del Vallès, Spain
- Unitat Mixta d'Investigació IRTA-UAB en Sanitat Animal, Centre de Recerca en Sanitat Animal (CReSA), Campus de la Universitat Autònoma de Barcelona (UAB), 08193, Bellaterra, Barcelona, Spain
- WOAH Collaborating Center for Research and Control of Emerging and Re-Emerging Pig Diseases (IRTA-CReSA), 08193, Bellaterra, Barcelona, Spain
| | | | - Sonia Cárceles
- Ceva Salud Animal, Avenida Diagonal, 609-615, 08028, Barcelona, Spain
| | - Carlos Casanovas
- Ceva Salud Animal, Avenida Diagonal, 609-615, 08028, Barcelona, Spain
| | - Patricia Prieto
- Inga Food S.A., Ronda de Poniente, 9, 28760, Tres Cantos, Madrid, Spain
| | | | - David Espigares
- Ceva Salud Animal, Avenida Diagonal, 609-615, 08028, Barcelona, Spain
| | - Joaquim Segalés
- Unitat Mixta d'Investigació IRTA-UAB en Sanitat Animal, Centre de Recerca en Sanitat Animal (CReSA), Campus de la Universitat Autònoma de Barcelona (UAB), 08193, Bellaterra, Barcelona, Spain.
- WOAH Collaborating Center for Research and Control of Emerging and Re-Emerging Pig Diseases (IRTA-CReSA), 08193, Bellaterra, Barcelona, Spain.
- Departament de Sanitat i Anatomia Animals, Facultat de Veterinària, UAB, 08193, Bellaterra, Barcelona, Spain.
| |
Collapse
|
4
|
Pérez E, Venegas-Vargas C, Heinz A, Smutzer M, Taylor LP, Diamondidis Y, Mangarova N, Hansen T, Angulo J, Bandrick M, Balasch M. Safety of the Administration of an Inactivated PCV2a/PCV2b/ Mycoplasma Hyopneumoniae Vaccine to Pregnant and Lactating Sows and Gilts. Vaccines (Basel) 2023; 11:1483. [PMID: 37766159 PMCID: PMC10537677 DOI: 10.3390/vaccines11091483] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2023] [Revised: 09/08/2023] [Accepted: 09/10/2023] [Indexed: 09/29/2023] Open
Abstract
Porcine Circovirus type 2 (PCV2) vaccination of gilts during acclimation has become a routine practice in commercial pig farms to homogenize herd immunity to PCV2 and reduce the impact of diseases associated with PCV2 infection, namely reproductive, respiratory, systemic, and other PCV2-associated diseases. The periodic mass vaccination of sows, with the same objectives, is also common. To ensure mass vaccination is an appropriate health management tool, demonstrating that the vaccine is safe in different sow/gilt physiological stages is necessary. The objective of the present studies was to evaluate safety of a PCV2a/PCV2b/Mycoplasma hyopneumoniae (PCV2a2bMHP) killed vaccine in sows and gilts during gestation and lactation, under controlled experimental pen conditions, and during gestation, mimicking mass vaccination, under field conditions. Safety was assessed by monitoring for immediate adverse reactions after vaccination, rectal temperatures after vaccination (controlled experimental pen studies only), local and systemic reactions, and reproductive performance (studies conducted during pregnancy) or lactation performance (studies conducted during lactation). In total, 416 sows/gilts were enrolled, and more than 4000 piglets were observed during their first week of life, under field conditions. In both controlled experimental and field studies, no immediate anaphylactic type reactions were observed after vaccination and the incidence of adverse events, such as depression or decreased appetite, was acceptable for what is expected in a swine herd. In the studies conducted during gestation, vaccination did not significantly increase rectal temperature of the vaccinated animals. Sow reproductive outcomes were not affected by vaccination. The farrowing rate of animals participating in the field study was higher than the historic averages of the farms. In the laboratory studies conducted during the first and second half of gestation, no differences in reproductive outcome were observed between vaccinated and non-vaccinated animals. However, sows vaccinated during lactation experienced a transient hyperthermia which did not affect milk production since the piglets' average daily weight gain was not affected. The previously described results confirm that the administration of a PCV2a2bMHP vaccine was safe in the tested conditions. All the anticipated benefits of sow and gilt PCV2 vaccination, such as homogenization of PCV2 antibody titers or reduction in PCV2 circulation in the herd, would not be masked by potential adverse events due to herd vaccination. In conclusion, the administration of a PCV2a2bMHP vaccine to sows and gilts during different stages of gestation and during lactation is safe.
Collapse
Affiliation(s)
- Elena Pérez
- Zoetis Manufacturing & Research Spain S.L., Ctra Camprodon s/n, 17813 Vall de Bianya, Spain;
| | - Cristina Venegas-Vargas
- Zoetis Inc., 333 Portage St, Kalamazoo, MI 49007, USA; (C.V.-V.); (A.H.); (M.S.); (L.P.T.); (Y.D.); (M.B.)
| | - Andrea Heinz
- Zoetis Inc., 333 Portage St, Kalamazoo, MI 49007, USA; (C.V.-V.); (A.H.); (M.S.); (L.P.T.); (Y.D.); (M.B.)
| | - Megan Smutzer
- Zoetis Inc., 333 Portage St, Kalamazoo, MI 49007, USA; (C.V.-V.); (A.H.); (M.S.); (L.P.T.); (Y.D.); (M.B.)
| | - Lucas P. Taylor
- Zoetis Inc., 333 Portage St, Kalamazoo, MI 49007, USA; (C.V.-V.); (A.H.); (M.S.); (L.P.T.); (Y.D.); (M.B.)
| | - Yvette Diamondidis
- Zoetis Inc., 333 Portage St, Kalamazoo, MI 49007, USA; (C.V.-V.); (A.H.); (M.S.); (L.P.T.); (Y.D.); (M.B.)
| | - Nevena Mangarova
- Zoetis Belgium S.A., 20 Mercuriusstraat, 1930 Zaventem, Belgium;
| | - Tara Hansen
- Zoetis Inc., 601 West Cornhusker Hwy, Lincoln, NE 68521, USA;
| | | | - Meggan Bandrick
- Zoetis Inc., 333 Portage St, Kalamazoo, MI 49007, USA; (C.V.-V.); (A.H.); (M.S.); (L.P.T.); (Y.D.); (M.B.)
| | - Monica Balasch
- Zoetis Manufacturing & Research Spain S.L., Ctra Camprodon s/n, 17813 Vall de Bianya, Spain;
| |
Collapse
|
5
|
Descriptive analyses of maternally-derived antibody levels against porcine circovirus 2 (PCV-2) in 3- and 21-day-old piglets from farms of four European countries using different vaccination protocols in sows. Porcine Health Manag 2022; 8:41. [PMID: 36192816 PMCID: PMC9531413 DOI: 10.1186/s40813-022-00284-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/11/2022] [Accepted: 09/09/2022] [Indexed: 11/24/2022] Open
Abstract
Background Up to now, information on the levels of maternally-derived antibodies (MDA) against PCV-2 in suckling piglets born to sows vaccinated with different strategies is scarce in the literature. In the present observational study, the PCV-2-specific MDA titres from piglets from 109 farms (thirty 3-day-old and thirty 21-day-old piglets per farm) across four different European countries (France n = 30, Germany n = 27, Italy n = 22 and Spain n = 30) using different sow vaccination strategies (during gestation, as a gilt, as a piglet or never) were assessed. Results In all four countries, mean log PCV-2 MDA titres were higher in 3-day-old piglets than in the 3-week-old ones, being significant in most of all the comparisons performed. Within each country, the highest PCV-2-specific MDA titres were observed in the 3-day-old piglets born to sows vaccinated during gestation. Indeed, in the four countries, more than 60% of this subpopulation (3-day-old piglets from sows vaccinated during pregnancy) had the highest log PCV-2 titres detectable with the ELISA technique used in this study. The lowest MDA titres were more variable. Whereas in France and Germany the lowest titres corresponded to 21-day-old piglets born from sows vaccinated as a piglet, in Italy, they corresponded to 21-day-old piglets derived from sows vaccinated as a gilt and in Spain to 21-day-old piglets born from non-vaccinated sows. In this study, PCV-2-specific MDA titres at 3 and 21 days of age were not affected by sow parity. Conclusions Data obtained could be considered as a European global overview of PCV-2-specific MDA titres present in the pre-vaccinated piglet populations in different European countries, with titres tending to be higher in younger piglets, but with values variable among countries and sow vaccination strategies. Supplementary Information The online version contains supplementary material available at 10.1186/s40813-022-00284-9.
Collapse
|
6
|
Revisiting Porcine Circovirus Disease Diagnostic Criteria in the Current Porcine Circovirus 2 Epidemiological Context. Vet Sci 2022; 9:vetsci9030110. [PMID: 35324838 PMCID: PMC8953210 DOI: 10.3390/vetsci9030110] [Citation(s) in RCA: 17] [Impact Index Per Article: 8.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/03/2022] [Revised: 02/25/2022] [Accepted: 03/01/2022] [Indexed: 02/01/2023] Open
Abstract
Current knowledge on porcine circovirus diseases (PCVD) caused by Porcine circovirus 2 (PCV-2) includes the subclinical infection (PCV-2-SI), systemic (PCV-2-SD) and reproductive (PCV-2-RD) diseases, and porcine dermatitis and nephropathy syndrome (PDNS). Criteria to establish the diagnosis of these conditions have not changed over the years; thus, the triad composed by clinical signs, lesions and viral detection in lesions are still the hallmark for PCV-2-SD and PCV-2-RD. In contrast, PCV-2-SI diagnosis is not usually performed since this condition is perceived to be controlled by default through vaccination. PDNS is diagnosed by gross and histopathological findings, and PCV-2 detection is not recognized as a diagnostic criterion. Molecular biology methods as a proxy for PCVD diagnoses have been extensively used in the last decade, although these techniques should be mainly considered as monitoring tools rather than diagnostic ones. What has changed over the years is the epidemiological picture of PCV-2 through the massive use of vaccination, which allowed the decrease in infectious pressure paralleled with a decrease in overall herd immunity. Consequently, the need for establishing the diagnosis of PCVD has increased lately, especially in cases with a PCV-2-SD-like condition despite vaccination. Therefore, the objective of the present review is to update the current knowledge on diagnostic criteria for PCVDs and to contextualize the interest of using molecular biology methods in the overall picture of these diseases within variable epidemiological scenarios of PCV-2 infection.
Collapse
|